ERBB2 and cancer: To learn why the sensitization effect of CHK1 inhibition on ADR toxicity differed between ER-/PR-/HER2- and ER+/PR+/HER2- cancer cells, we measured levels of mRNA, protein and chemical modifications for CHK1 using RT-qPCR and Western blot.